透過您的圖書館登入
IP:18.119.248.13
  • 期刊

后疫情时代医药行业的数字化转型研究

Research on digital transformation of the pharmaceutical industry in the post-epidemic era

摘要


2020年初,突发的疫情给我国经济社会发展带来了巨大的风险和挑战,同时也为我国医药行业孕育出了变革与发展的机遇。本文对医药行业的发展现状进行了评价与分析,并聚焦于后疫情时代背景下医药行业的数字化转型。通过文献梳理、案例与理论分析等方法深入研究,最后从不同主体角度为医药行业的数字化转型提供了方向,也为政府和投资者提供了参考依据。

並列摘要


At the beginning of 2020, sudden epidemic has brought huge risks and challenges to my country's economic and social development, and it also gave birth to change and development opportunities for my country's pharmaceutical industry. This paper evaluates and analyzes the current development status of the pharmaceutical industry, focusing on digital transformation of the pharmaceutical industry in the background of the postpartum epidemic. Through the method of literature card, case and theoretical analysis, etc., and finally, the digital transformation of the pharmaceutical industry will provide a direction from different subject angles, but also provide reference for government and investors.

延伸閱讀